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Prevention of the induced synthesis and secretion of group II 
phospholipase A, by brefeldin A 
Rosa M. Sbchez*, Margriet J.B.M. Vervoordeldonk, Casper G. Schalkwijk, Renk van den Bosch 
Brefeldin A (BFA) has previously been shown to block protein secretion and to cause disman~~g of the Golgi cisternae in many cultured cell lines. 
BFA was found to prevent he induced synthesis and secretion of 14 kDa group II pbospholipase A, (PLAJ in rat mesangial cells. Furthermore, 
BFA inhibited total protein synthesis although PLA, appeared to be more sensitive to the effect of this compound than total protein synthesis 
assessed by amino acid incorporation. BFA was unable to block protein synthesis or PLA, activity in the cell completely but secretion of enzymatic 
activity and PLA, protein into the cell culture media was totally inhibited. 
14 kDa group II phospholipase AZ; Brefeldin A, Golgi structure; Inhibition of protein synthesis and secretion; Rat renal mesaugial cell 
1. ~TRO~U~TI~N 
Group II phospho~pase A, is believed to participate 
in inducing and maintaining infla~ato~ reactions, 
although the pro-infiammatory activity of group II 
PLAz has only been shown indirectly [l--6]. Previous 
studies, using cultured rat glomerular mesangial cells, 
demonstrated that the potent inflammatory cytokines 
interleukin-l/3 (II-lp) and tumor necrosis factor induced 
the synthesis and secretion of group II PLA2. Over 85% 
of this de novo~synthesized group II PLAz appears to 
be rapidly secreted from the ~ytokine-s~rn~at~ cells 
151. We tried to accumulate the enzyme in fl-l@imu- 
lated cells by blocking the secretion of group II PLA, 
in order to study the contribution of this enzyme to 
arachidonate release and prostaglandin synthesis. For 
this purpose we used a known inhibitor of protein secre- 
tion, brefeldin A (BFA). BFA was initially described as 
a reversible inhibitor of the intracellular transport of 
newly synthesized membrane and secretory proteins 
that did not affect protein synthesis or endocytosis [7- 
91. It was shown later that these effects are due to disor- 
ganization of the Golgi complex the membranes of 
which apparently fuse with the endoplasmic reticulum 
1711q* 
In this manuscript we demonstrate that BFA pro- 
foundly alters the structure of the Golgi complex in 
mesangial cells. As expected, this blocked PLA2 secre- 
tion, but Western blot analysis showed that this was not 
accompanied by an increase in the cellular level of 
*Corresponding author. Fax: (31) (30) 522 478. 
PLAI, Subs~~ent results showed that IL-ljG.nduced 
synthesis of group II PLA, was don-de~ndently pre- 
vented by BFA. In addition, total protein synthesis was 
inhibited by BFA, although not to the same extent as 
cytokine-induced synthesis of group II PLA,. 
2. MATERIALS AND METHODS 
2.1. Materials 
Recombinant II-l@ was prepared by the Biotechnology Department 
of Ciba Geigy Ltd, Basel, Switzerland. [l-‘4ClLinoieic acid and L-[4,5- 
3H]leucine (45-70 Ci/mmol) were obtained from Amersham, Bucks., 
UK. l-Acyl-2[l-~4~inoieoylphospha~dyIethanol~ne was prepared 
bios~~eti~ly by incubating rat liver microsomes w&b [l-‘4CJlinoIeic 
acid and ~ophosphatidylethanol~e, as pre~ously described [SJ. 
Nitr~lI~o~ membranes were from Schleicher and Schull, Dassel, 
Germany. Alkaline phosphatase~njugat~ goat anti-mouse immu- 
noglobulines (GAMAP) and pre-stained markers were obtained from 
Bio-Rad laboratories. Nitro blue tetraxolium and 5-bromo+ chloro- 
3-indolyl phosphate, the Golgi marker, Ricinus commwris agglutinin- 
TRITC, and BFA were obtained from Sigma, St. Louis, MO. BFA 
was stored as a stock solution of 1 mg/ml in ethanol at -40°C. Mon- 
oclonal antibodies against group II PLA, were prepared as described 
before (Ii]. Fluorescein isothiocyanate-labeled goat anti- mouse IgG 
(GAM-FITC) was from Nordic Laboratories, Tilburg, The Nether- 
lands. 
Mealy cells were cultivated and &har~te~~ as has been de- 
scribed pre~o~ly 1121. The cells were grown in RPM1 1640 suppie- 
mented with 11% (v/v) fetal calf serum, penicillin (100 U/ml), strepto- 
mycin (10 #g/ml) and insulin (0.66 U/ml). Only cells up to passage 27 
were used for the experiments. Confluent mesa&al cells cultured in 
25 cm’ tissue culture flasks were washed once with phosphate-butfered 
saline (PBS) and incubated with 5 ml DMEM containing 0.1 mg/ml 
of fatty acid-free bovine serum albumin with or without B-l/I or BFA 
at the indicated concentrations. The control and II-l/&stimulated cells 
received an equivalent amount of ethanol to that received by the cells 
incubated with BFA. ABer the indicated time periods the supernatants 
were removed and assayed for PLA, activity. When the cells had to 
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be used for further analysis they were rinsed once with PBS and 
scraped with a plastic policeman into 50 mM HEPES, pH 7.4, 0.25 
M sucrose, 1 mM EDTA, 1 mM EGTA, 1 @I pepstatin A, 50 PM 
NaF, 250 ,uM Na,VO,, 10 PM leupeptin, 1 mM phenylmethanesul- 
fonyl fluoride (PMSF) and 0.02% azide. The cells were homogenized 
with 10 strokes of a Potter-Elvehjem motor-driven teflon pestle at600 
rpm and stored frozen until assayed. 
2.3. PLAz and protein assay 
PLA, activity was assayed using 0.2 mM sn-2-labeled [l-“‘C&no- 
leoylphosphatidyle~~ol~e (specific activity 3,OOQ dp~~ol) in 
0. I M Tris-HCI, pH 8.5, in the presence of IO mM CaCl, and 0.05% 
Triton X-100 as previously described IS]. This assay employs the pref- 
erence of group II PLAz for phosphatidylethanol~ine and suppresses 
the activity of a high molecular weight PLA, which has a preference 
for sn-2-arachidonoyl phospholipids. Under these conditions the con- 
tribution of the high molecular weight PLA, to the total measured 
PLAz activity amounts to less than 5% in control cells and less than 
0.5% in IL-l/l-stimulated cells. We have previously shown that the 
culture medium contains only group II PLA, and no high molecular 
weight PLA, [5,6]. Protein was determined according to Bradford [13] 
with bovine serum albumin as a standard. 
2.4. Western blotting 
SDS-PAGE using 15% ~ly~lamide gels was done according to 
Laemmli 1141 at a constant voltage of 200 V. For ~~oblott~g the 
proteins were transferred to nitrocellulose at 2 mA/cm2 for 1.5 h and 
immunodetected with monoclonal antibodies against PLA, (160 dilu- 
tion) according to a standard procedure [5]. 
2.5. immuno~u0rescence 
Rat mesangial cells grown on glass coverslips were stimulated with 
the indicated agents. The coverslips were rinsed twice with PBS, tixed 
30 min in 3% paraformaldehyde in PBS and washed twice with PBS. 
All incubation and washing steps were performed at room tempera- 
ture. After permeabilization in 0.1% Triton X-100 for 5 min and 
quenching with 50 mM glycine in PBS for 5 min, the samples were 
washed twice with PBS containing 0.1% gelatin and 0.5% BSA (de- 
noted as PBG). The coverslips were incubated with a monoclonal 
antibody against rat group II PLAz (1:5 ~ution). After six 5 min 
washes in PBG, the coverslips were incubated for 1 h with both 
fluorescein isothi~yanate-laxly goat anti-mouse IgG (GAM-FITC, 
dilution 1:200) for detection of PLA*, and tetramethylrhodamine iso- 
A 
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thiocyanate conjugated to the Golgi marker, Ricks cowununis agglu- 
tinin (RCA 120_TRITC, dilution 1: 100). After washing with PBG six 
times and once with distilled water, the preparations were embedded 
in Mowiol 4-88, 10% glycerol and 100 nM 1,4-diazobicyclo (2,2,2)- 
octane buffered with Tris, pH 8.3. The covet-slips were examined with 
a Leitz orthoplane microscope (x 63 oil objective lens). The micro- 
scope was equiped with a double channel fllter set with excitation lens 
at 488 nm and 514 nm and emission filters at 515 nm and 550 nm, thus 
allowing separation of the green (fluorescein) and red (rhodamine) 
images. The coverslips were photo~aph~ on Kodak Tri-X him. 
2.6. incorporation of r3H~~~~ into cell&r proteim 
Confluent mesangial cells grown in 22 mm diameter wells were 
washed once with PBS and incubated with 1 ml DMEM containing 
0.1 mglml fatty acid-free bovine serum albumin. The cells were pulsed 
with 2 ,&i/well of [4,5-311Jleucine for 24 h. II-l/I and BFA were added 
to the medium at the concentrations indicated simultaneously with 
labeled leucine. Thereafter the medium was removed and the cells were 
washed two times with ice-cold PBS. The cell monolayer was removed 
from the bottom of the well by adding 2 ml/well of 8 mM EGTA PBS. 
The cells were pelleted by centrifugation at 2000 g for 5 min. The pellet 
was resuspended in 20 mM Tris-HCl, pH 7.4, 1mM EGTA, 1 mM 
PMSF and son&ted. Aliquots of 50 ~1 and 30 ~1 from each sample 
were spotted on Whatmann 3MM 8lter papers. The 8lters were dried 
at room temperature. The protein was precipitated on the filter paper 
by washing them in 10% TCA for 15 min. Then, the filters papers were 
washed successively for 15 min each in lo%, 5% and 1% ice-cold TCA 
to remove traces of free [4,5-3H]leucine. The filters were air-dried and 
transferred to scintillation vials. The radioactivity incorporated into 
proteins was measured by scintillation counting [1.5]. In pilot studies 
we tested this method (A) with the standard method of TCA precipi- 
tation and centrifugation as reference (B) [16]. The results showed that 
the DPM incorporated in control samples were almost identical in 
both methods (657,752 + 73,046 and 716,922 f 62,890 dpm/mg pro- 
tein for A and B, respectively). 
3. RESULTS 
It has been reported previously that incubation of rat 
giomerular mesa&al cells with II-@ induced synthesis 
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BFA (MS/ml) 0 0 0.05 0.1 0.5 1 10 
Fig. 1. Dose-dependent inhibition of IL-l&induced secretion of PLA, by BFA. Con&tent monolayers of mesangial cells were incubated for 24 
h with the indicated concentrations of Ii-@ and BFA. Thereafter, the culture supematants were withdrawn and analyzed for PLAr activity (A) 
and PLAz protein by Western blotting and ~~os~~g (B). In panel A, data are expressed as the mean + S.D. from three separate xperiments. 
The value of PLA, activity for control was 0.395 + 0.065 nmo~mi~ml. In panel B, a ~p~~ntative experiment out of a series of three is depicted. 
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IL- 18 (nM) 0 1 1 1 1 1 1 
BFA @g/ml) 0 0 0.05 0.1 0.5 1 10 
Fig. 2. Dose-dependent inhibition by BFA of the synthesis of PLA, 
upon IL-l#? stimulation of mesa&al cells. Confluent monolayers of 
mesangial cells were incubated for 24 h with the indicated concentra- 
tions of IL-@ and BFA. After the incubation period the media were 
removed and the cell layers were rinsed, scraped and resuspended. 20 
pug of protein from cell homogenates was nsed for Western blotting 
and immunostaining as described in section 2.4. 
and secretion of group II-PLA,. Treatment of the me- 
sangial cells with increasing con~ntrations of BFA 
gradually decreased the secretion of PLAz activity. In 
these experiments BFA was added together with the 
cytokine. When the concentration of BFA in the me- 
dium was 0.5 ,q$nl, the 11-l/?-induced secretion of PLAz 
activity was completely inhibited, resulting in PLA, ac- 
tivities even lower than control values (Fig. 1A). These 
results were supported by the immunoblot experiments 
(Fig. 1B). As can be seen in Fig. lB, PLA, could not be 
detected on the immunoblots of the culture medium of 
unstimulated cells. After stimulation of the cells with 
IL-l/l the protein became detectable in the culture su- 
pe~atants, in full agreement with previous results 
which have also shown that this secretion followed de 
novo synthesis of PLAZ protein [3,5]. The PLAZ signals 
on immunoblots of the media from BFA-treated cells 
were gradually reduced and became undetectable at 0.5 
&ml of BFA in accord with the values of PLAZ activ- 
ities in the culture supernatants. 
3.2. BFA prevents the induced synthesis of PLAE in me- 3.4. Effect of BFA on total protein synthesis 
sangial cells 
In order to investiage whether the reduced levels of 
PLA, activity and PLAZ protein in the culture superna- 
tants were due to an in~bition of PLA, secretion and 
hence caused an ambulation of the induced PLAZ in 
the cells, the PLAZ protein levels in the cells were ana- 
lyzed. Surprisingly, immunoblots from the treated cells 
showed that BFA did not cause an accumulation of 
PLAl in the cells. Rather, the drug prevented the de 
novo synthesis of PLA, protein, as induced by IL-l/?, 
at the same concentrations that blocked the PLAZ secre- 
tion (Fig. 2). However, although we did not detect cellu- 
lar PLA2 protein levels at 0.5 &ml, the PLA,, activity 
The effect of varying concentrations of BFA on the 
incorporation of [4,5-3E[lleucine to the cellular proteins 
and PLA, was tested in mesa&al cells. Tbe results 
showed a different pattern for PLA, activity and protein 
synthesis (Fig. 4). Total protein synthesis remained un- 
affected at BFA concentrations up to 0.1 @ml and 
became about 50% inhibited at 0.5 and 1.0 @g/ml of 
BFA. By contrast, the IL-l@induced synthesis of PLA, 
activity was more sensitive to BFA, both with respect 
to BFA concentration and magnitude of the inhibition 
(Fig. 4). However, again it was not possible to totally 
inhibit either protein synthesis or PLA, activity even at 
the highest concentration used (1 .O yg/ml BFA). 
could not be totally inhibited even at the highest concen- 
trations of BFA (75 and 78% inhibition of PLA, activity 
from 11-l&stimulated cells at 1 .O and 10.0 &ml) of 
BFA. In view of the intensities of the stained bands we 
cannot exclude the possibility that PLA2 enzymes other 
than the immunoreactive group II PLA, contribute to 
these residual activities. 
3.3. Effects of BFA on the Golgi apparatus in mesangial 
cells: immuno~~rescence localization of PLAz in 
BFA-treated cells 
We studied the effect of BFA on the Golgi apparatus 
and on group II PLAZ levels in IL-lo-stim~ated cells. 
In these experiments, the same concentrations of BFA 
as applied in previous experiments (0.05, 0.1, 0.5, 1.0, 
10.0 ,@nl) were used. In accord with previous studies 
[ 181, in unstimulated cells negligible immunofluorescent 
labeling of PLAZ was obtained (data not shown). As 
shown in Fig. 3, in IL-lJI-stimulated cells intense fluo- 
rescence near the nucleus was observed for both the 
Golgi marker and the PLA,. Treatment of rat mesangial 
cells with increasing concentrations of BFA caused 
marked changes in the morphology of the Golgi appa- 
ratus. Whereas in IL-l~-st~~at~ cells it showed a 
compact shape nearby the nucleus, at 0.1 &ml of BFA 
a circular staining around the nucleus was observed, 
and at 0.5 @ml all the cells had a totally disorganized 
Golgi, as shown by the appearance of a fine punctuate 
immunofluorescence pattern. This was even more pro- 
nounced at the highest concentrations (1 .O and 10.0 
,@ml), although at those levels many dead cells were 
found after a 24 h incubation with BFA and Ii-@. 
Phase-contrast micrographs of cells treated with up to 
0.5 &ml of BFA showed similar shapes to those found 
in IL-l~-s~~at~ cells (data not shown). With regard 
to the staining of PLA, in BFA-treated cells, there was 
no apparent difference in the localization of the staining 
of PLA, found in IL-l@irnulated cells and that in the 
cells treated with 0.05 /.&ml of BFA. As expected, the 
staining gradually decreased when BFA concentration 
increased, hence at 0.5 fig/ml of BFA we could hardly 
detect any staining. 
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Fig. 
in se 
3. Localization f group II PLAz and Golgi marker in stimulated cells treated with BFA. Rat mesangial cells grown on glass coverslips 
ed with IL-l/j (A,B), IL-l@ plus 0.1 @ml BFA (C,D) or IL-@ plus 0.5 ,ug/ml BFA (E,F). Immunofluorescence was carried out as desc 
ction 2.5. The Golgi localization, as detected with RCA120-TRITC, is shown in panels A, C and E, and the PLA, localization, detected 
McAb-GAM-FXTC complex, is shown in panels B, D and F. 
were 
ribed 
with 
The fungal metabolite, brefeldin A, has been used by 
many groups to study membrane traffic in the secretory 
pathway. BFA has been shown to block secretion and 
alter the structure of the Golgi complex [7] but little is 
known about the effect of this compound on other sys- 
tems. We found that BFA prevented the induced syn- 
thesis and secretion of group II PLAz in mesangial cells. 
We expected a blockage of the secretion and eonse- 
quently an adulation of the enzyme in the cell. How- 
ever, while secretion was blocked there was no accumu- 
lation but rather a decrease in the cellular PLAz protein 
levels (Fig. 2). Thus, the decrease in PLA, activity and 
protein levels in the culture supernatants could poten- 
tially have been caused solely by an inhibition of the 
induced PLAz synthesis without affecting protein seere- 
tion. However, there seemed to be two different effects 
of the drug as the PLAz activity in the medium, but not 
in the cells, could be totally blocked. It has been re- 
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Fig. 4. Effect of BFA on total protein synthesis and PLAz activity in 
stimulated mesangial cells. Confluent monolayers of mesangial cells 
incubated for 24 h with 1 nM IL-l/3 and 2 @Zi [4,5-‘H]leucine/well in 
the absence and in the presence of 0.05, 0.1, 0.5 and 1.0 pg/ml BFA. 
The cells were then assayed for protein synthesis (0) and PLA, activity 
(e) as described in sections 2.6 and 2.3, respectively. Data are ex- 
pressed as the mean + S.D. from three separate experiments 
(100% = 628,564 f 35,440 dpm [4,5-3H]leucine incorporated/mg pro- 
tein for protein synthesis, and 1.54 + 0.32 nmol/min/mg for PLAl 
activity). 
ported that not all cell lines are equally sensitive to 
BFA, some of them even being totally insensitive [17]. 
Therefore, first of all, we tested the effect of BFA on the 
Golgi complex in rat mesangial cells and checked if 
BFA only prevented the induced synthesis of PLA2, 
thereby decreasing the protein levels inside and outside 
the cell, or whether also disorganization of the Golgi 
complex, and hence inhibition of protein secretion, took 
place. Double immunofluorescence studies showed an 
obvious alteration of the morphology of the Golgi com- 
plex by BFA. The structure of this organelle began to 
be modified at 0.1 &ml of BFA, and at 0.5 ,&ml it was 
almost completely disassembled (Fig. 3). As was ex- 
pected, at these concentrations (0.5-10.0 &ml) the 
PLA, activity in the culture supernatants was practi- 
cally insignificant since the protein secretion was totally 
blocked (Fig. 1A). In accord with previous studies [18] 
PLAz was detected in the Golgi apparatus (Fig. 3B). 
BFA-treated cells showed a lower staining in compari- 
son to cells receiving only IL-l/?. Thus, the staining at 
0.5 &ml is practically negligible (Fig. 3F), in full agree- 
ment with the inhibition of PLA, synthesis detected in 
the immunoblots (Fig. 2). Therefore, treatment of rat 
mesangial cells with BFA caused both the blockage of 
the protein secretion, due to the disassembly of the 
Golgi complex, and the inhibition of induced PLA, syn- 
thesis. 
Many secretory proteins are proteolytically processed 
after leaving the endoplasmic reticulum. This process- 
ing occurs in both the Golgi complex and in secretory 
vesicles and it is, to a large extent, highly specific [22]. 
Some authors have reported that BFA inhibited the 
proteolytic processing of envelope glycoproteins in cells 
infected with virus [23]. Whether proPLAz is processed 
proteolytically in the Golgi remains to be elucidated. 
Nevertheless, PLAz appears to be more sensitive to the 
effects of BFA, and thus at lower concentrations of this 
compound, in the first steps of the Golgi disassembly, 
this processing/secretion of PLA, was already blocked. 
As a result_ of this blockage, the cell could react by 
blocking the synthesis of this protein by a feed-back 
mechanism without affecting total protein synthesis. It 
would not be possible to detect this inhibition by meas- 
urement of total protein synthesis because the amount 
of PLAZ is not significant with respect to the total 
amount of cellular protein. At higher concentrations of 
BFA (0.5, 1 .O ~g/ml), the% inhibition of protein synthe- 
sis was closer to that found for PLAl activity, although 
the latter was always higher. Under these conditions the 
decrease in PLAz activity might be only due to the pro- 
tein synthesis inhibition. Nevertheless, it should be 
pointed out that at these concentrations two effects are 
taking place simultaneously in the cell: the inhibition of 
the synthesis and the blockage of the secretion of PLA,. 
Since after Il-lp stimulation over 85% of PLAZ activity 
is secreted [5], we detect only 15% of the total enzymatic 
activity by assaying cell homogenates. However, in 
BFA-treated cells all the PLAz activity is detected be- 
cause the protein secretion is blocked. The residual 30% 
activity in these cells was calculated against the 15% of 
activity remaining in IL-l/?-stimulated cells not receiv- 
ing BFA. Since these cells in total synthesize about 6- 
fold more PLA*, the percentage residual activity would 
be only about 5% of that totally synthesized. Thus, the 
inhibition by BFA of the IL-l/?-induced synthesis of 
PLAz may be as high as 95%. 
BFA has been widely used in cell biology and it has In summary, next to the well-known effect of BFA on 
been reported that this compound does not affect pro- Golgi disassembly, this drug inhibits protein synthesis, 
tein synthesis [8,16,17,19,20]. However, while our stud- although the synthesis of all proteins does not appear 
ies were in progress Fishman and Curran have recently to be inhibited to the same extent. Those proteins proc- 
shown that BFA inhibits protein synthesis in rat glioma essed/secreted via the Golgi complex, like PLA2, may be 
C6 cells and, to minor extent, also in other cell lines [21]. more sensitive. The mechanism through which BFA 
It may thus be that this additional effect of BFA is cell inhibits protein synthesis remains unclear. It has been 
type-dependent. Therefore, we decided to test it in rat 
mesangial cells to investigate whether BFA had a spe- 
cific effect in suppressing induced PLAZ synthesis or 
whether this resulted from a general effect on total pro- 
tein synthesis. In these experiments the cells were ana- 
lyzed both for total protein synthesis and PLAz activity. 
BFA inhibited the [31-Ijleucine incorporation into cellu- 
lar proteins approximately 50% at 0.5 and 1.0 ,@ml, 
but no inhibition was observed at lower concentrations. 
However, PLA, activity was already inhibited over 60% 
at 0.1 &ml of BFA (Fig. 4). 
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shown by electron ~~~raphs that in human lmg fr- 
broblast after in~~b~~o~ with BFA for 6 b, the endo- 
plasmic retinae is devoid of ribosomes [24]* This ef- 
fect could explain an inhibition of total protein synthe 
sis. Nevertheless, in rat mesangial cells, both total pro- 
tein synthesis and PLAz activity could not be totally 
inhibited as would be expected if the endoplasrnic mtic- 
ulum lacked ribosomes. Some authors have postulated 
that disruption of ~~t~~~ll~ar traffic~n~pro~ssi~~ by 
BFA may iead to ~~~ppr~piate processing or Io&rzata- 
tion of some factors required for protein synthesis &?I], 
This may explain why BFA did not totally ~~ibit pro- 
tein ethyls, Even tbongh we can not discard a direct 
effect of BFA on protein synthesis it seems more likely 
that this eBTec% was mediated by the Golgi disassembly, 
and in view of the results found, some secretory proteins 
that could be processed in the Golgi appear to be more 
sensitive to the effect of BFA on this complex. 
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